These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2779065)

  • 1. [Effect of ethacizine on the chronic stimulation threshold].
    Kostyleva OV; Votchal FB; Grigorov SS
    Kardiologiia; 1989 Jun; 29(6):105-7. PubMed ID: 2779065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of ethacizine on the heart conduction system and the indicators of central hemodynamics].
    Gorshkov VA; Nesvetov VN; Kesarev GV; Sherashov VS; Mamaev VI
    Sov Med; 1991; (8):9-11. PubMed ID: 1763379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combined effect of 2 first-line anti-arrhythmia drugs on the conduction velocity of myocardial stimulation].
    Nesterenko VV; Aniukhovskiĭ EP; Starmer ChF; Beloshapko GG; Ivanovich T; Bugriĭ EM; Mazaev AV; Rozenshtraukh LV
    Kardiologiia; 1990 Mar; 30(3):81-7. PubMed ID: 2381129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder].
    Smetnev AS; Shugushev KhKh; Rozenshtraukh LV; Shevchenko NM
    Ter Arkh; 1983; 55(1):92-5. PubMed ID: 6340241
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy of ethacizine in tablet form in the treatment of arrhythmias].
    Lozinskiĭ LG; Sandomirskiĭ BL; Maksimova LN; Mutin SS
    Klin Med (Mosk); 1988 Nov; 66(11):50-5. PubMed ID: 3236807
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-arrhythmia treatment (clinical problems, classification of anti-arrhythmia drugs and personal experience].
    Walczak F
    Kardiol Pol; 1992; 36(2):97-104. PubMed ID: 1583833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F
    Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832
    [No Abstract]   [Full Text] [Related]  

  • 8. [The characteristics of the action of ethacizine and its combination with digoxin and glutamic acid on the hemodynamic indices and myocardial contractile capacity in patients with a heart rhythm disorder].
    Zapevina VV; Poliakova LA; Nikolaeva SA
    Ter Arkh; 1990; 62(9):51-4. PubMed ID: 1980753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between the chemical structure and the antiarrhythmic action of ethacizine and its analogs].
    Turilova AI; Berdiaev SIu; Grishchenko AN; Senova ZP
    Farmakol Toksikol; 1990; 53(6):20-1. PubMed ID: 2081560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic characteristics of ethacizine in patients with disorders of heart rhythm].
    Gneushev ET; Kurapov AP; Beliakova GA; Zagrebin SV; Starodubtsev AK
    Farmakol Toksikol; 1987; 50(4):42-4. PubMed ID: 3666115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of arrhythmia in ambulatory practice].
    Pomerantsev VP
    Sov Med; 1990; (8):36-40. PubMed ID: 2274818
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
    Smetnev AS; Ponomarenko EL; Koltunova MI; Shugushev KhKh
    Kardiologiia; 1987 May; 27(5):24-6. PubMed ID: 2443743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ventricular arrhythmias.
    Fogoros RN
    Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
    [No Abstract]   [Full Text] [Related]  

  • 14. [Arrhythmia. Its management at the leading British center].
    Kułakowski P
    Kardiol Pol; 1992; 36(2):106-9. PubMed ID: 1583825
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J; Zhou J; Patel C; Yan GX
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmic properties of ethmosine (clinico-experimental study)].
    Kaverina NV; Senova ZP; Lyskovtsev VV
    Kardiologiia; 1978 Apr; 18(4):67-72. PubMed ID: 671970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmogenic effects of anti-arrhythmia drugs].
    Popławska W
    Pol Arch Med Wewn; 1991 Aug; 86(2):61-4. PubMed ID: 1775391
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic management of arrhythmias.
    Ganjehei L; Massumi A; Nazeri A; Razavi M
    Tex Heart Inst J; 2011; 38(4):344-9. PubMed ID: 21841856
    [No Abstract]   [Full Text] [Related]  

  • 19. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmogenic effect of anti-arrhythmia drugs: incidence, possible mechanisms and therapeutic tactics].
    Abdalla A; Mazur NA; Shestakova NV; Sumarokov AB
    Kardiologiia; 1990 Jan; 30(1):95-100. PubMed ID: 2186189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.